Number of the records: 1
Tumour MHC class I downregulation and immunotherapy (Review)
- 1.0191678 - UMG-J 20033193 RIV GR eng J - Journal Article
Bubeník, Jan
Tumour MHC class I downregulation and immunotherapy (Review).
Oncology Reports. Roč. 10, č. 6 (2003), s. 2005-2008. ISSN 1021-335X. E-ISSN 1791-2431
R&D Projects: GA MZd NC7148; GA ČR GA301/01/0985; GA AV ČR IAA5052203
Institutional research plan: CEZ:AV0Z5052915
Keywords : tumour vaccines * MHC class I downregulation
Subject RIV: FD - Oncology ; Hematology
Impact factor: 1.256, year: 2003
The purpose of this review is to discuss the positive results of MHC class I- tumour treatment obtained with immunomodulatory cytokines and tumour vaccines, as well as the prospects and limitations of such therapy.
Permanent Link: http://hdl.handle.net/11104/0087416
Number of the records: 1